ZITANEO-DAPA-100/10 (Sitagliptin Phosphate and Dapagliflozin Tablets): Uses, MOA, Benefits, and Recommended Dosage

  • Post category:Blog
  • Post comments:0 Comments
  • Reading time:7 mins read


ZITANEO-DAPA 100/10, a pioneering offering by Invision Medi Sciences, introduces a potent combination of Sitagliptin Phosphate and Dapagliflozin Tablets. This guide unravels the uses, benefits, recommended dosage, and unique features of ZITANEO-DAPA 100/10, embodying the synergy of Sitagliptin and Dapagliflozin for optimal diabetes management.

Synergistic Control: Sitagliptin Phosphate and Dapagliflozin:

ZITANEO-DAPA 100/10 combines Sitagliptin Phosphate, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Dapagliflozin, a sodium-glucose co-transporter-2 (SGLT2) inhibitor. Dive into how this synergistic duo addresses multiple facets of diabetes for precise control.

Indications for ZITANEO-DAPA 100/10:

  1. Dual Pathway Control: ZITANEO-DAPA 100/10 is indicated for individuals seeking dual pathway control of blood glucose levels in type 2 diabetes.
  2. Glucose Excretion Enhancement: Dapagliflozin’s SGLT2 inhibition reduces glucose reabsorption, promoting its excretion in urine.

Benefits of ZITANEO-DAPA 100/10:

  1. Dual Mechanism: Sitagliptin Phosphate enhances insulin secretion, while Dapagliflozin promotes glucose excretion, offering a dual approach to diabetes management.
  2. Cardiorenal Protection: Dapagliflozin provides cardiovascular and renal benefits, contributing to overall well-being.

Recommended Dosage:

Healthcare providers tailor the dosage of ZITANEO-DAPA 100/10 based on individual health needs. Adherence to the prescribed dosage is crucial for optimal diabetes management.

Potential Side Effects:

ZITANEO-DAPA 100/10 is generally well-tolerated, but some individuals may experience mild side effects:

  • Gastrointestinal Distress: Occasional gastrointestinal discomfort may occur.
  • Polyuria: Dapagliflozin may lead to increased urine production.

Essential Information:

  1. Regular Monitoring: Routine blood glucose monitoring is recommended for proactive diabetes management.
  2. Patient Education: Patients are educated on recognizing and managing potential side effects.


ZITANEO-DAPA 100/10, featuring Sitagliptin Phosphate and Dapagliflozin Tablets, exemplifies Invision Medi Sciences’ commitment to innovative diabetes care. The dual mechanism and cardiorenal benefits align with the vision of fostering optimal well-being.

Related Combinations:

Explore our diverse range of diabetes management solutions at Invision Medi Sciences.

ZITANEO-DAPA 100/10: Harnessing the synergy of Sitagliptin Phosphate and Dapagliflozin for precise diabetes control.


How does the combination of Sitagliptin and Dapagliflozin work together for diabetes control?

ZITANEO-DAPA 100/10 combines these agents to address multiple pathways for comprehensive diabetes management.

Can ZITANEO-DAPA 100/10 be used as a monotherapy for type 2 diabetes?

ZITANEO-DAPA 100/10 is formulated for comprehensive control and is often prescribed as part of a holistic treatment plan.

Are there dietary restrictions while using ZITANEO-DAPA 100/10?

While specific dietary restrictions may not be required, maintaining a balanced diet is essential for overall diabetes management.

How soon can the benefits of ZITANEO-DAPA 100/10 be observed in glycemic control?

The time for noticeable benefits may vary. Consistent use and adherence to the prescribed dosage are essential for optimal results.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.